AI significantly accelerates drug discovery processes, reducing development time and costs. Intelligent systems enhance patient care through advanced diagnostics and personalized medicine. AI improves clinical trial success rates by optimizing patient selection and data analysis. Ethical concerns regarding data privacy and algorithmic bias require careful consideration. The future anticipates the growth of AI-first biotechnology companies and continued innovation.